| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2008 | CA2403190C Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis |
| 05/06/2008 | CA2142746C Rev-independent hiv expression and replication |
| 05/06/2008 | CA1341572C Protective antibodies to serotypic determinants of flagellar antigens |
| 05/02/2008 | WO2008052043A2 Opioid receptor agonist fusion proteins |
| 05/02/2008 | WO2008051852A2 Extracellular matrix cancer vaccine adjuvant |
| 05/02/2008 | WO2008051797A2 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/02/2008 | WO2008051526A2 Bone morphogenetic proteins |
| 05/02/2008 | WO2008051447A2 Human salty taste receptor and methods of modulating salty taste perception |
| 05/02/2008 | WO2008051306A1 Soluble tnf receptors and their use in treatment of disease |
| 05/02/2008 | WO2008051048A2 Method and materials for inhibiting a nuclear export of gsk3 |
| 05/02/2008 | WO2008050935A1 A preparation of an artificial transcription factor comprising zinc finger protein and transcription factor of prokaryote, and a use thereof |
| 05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 05/02/2008 | WO2008050897A1 Metastin derivatives and use thereof |
| 05/02/2008 | WO2008050830A1 Anti-hiv agent |
| 05/02/2008 | WO2008050825A1 Method of producing basement membrane collagen |
| 05/02/2008 | WO2008050774A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 05/02/2008 | WO2008050161A2 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 05/02/2008 | WO2008050139A2 Laminin binding site |
| 05/02/2008 | WO2008050133A2 Inhibition of beta-amyloid aggregation |
| 05/02/2008 | WO2008049974A2 Peptide vaccine for influenza virus |
| 05/02/2008 | WO2008049953A1 In vitro method for prognosis and/or diagnosis of hypersensitivity to ooestrogens or to substances with ooestrogenic activity |
| 05/02/2008 | WO2008049945A1 Neuronal exocytosis inhibiting peptides |
| 05/02/2008 | WO2008049942A1 Enzymatic collagen hydrolysate and method for obtaining same |
| 05/02/2008 | WO2008049931A1 Peptide extended insulins |
| 05/02/2008 | WO2008049920A2 Il-21 variants |
| 05/02/2008 | WO2008049888A1 Use of measles virus nucleoprotein for treating atherosclerosis |
| 05/02/2008 | WO2008049865A2 Methods for increasing the resistance in plants to biotropic fungi |
| 05/02/2008 | WO2008049711A1 Peptide extended insulins |
| 05/02/2008 | WO2008049583A2 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | WO2008049367A1 The use of plant seed protein extract and the pharmaceutical composition thereof |
| 05/02/2008 | WO2008049330A1 Use of lipocalin-2 as a diagnostic marker and therapeutic target |
| 05/02/2008 | WO2008049329A1 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 05/02/2008 | WO2008049239A1 Endometrial biomarkers |
| 05/02/2008 | WO2008049230A1 Ptra gene and uses therefor |
| 05/02/2008 | WO2008049225A1 Methods for diagnosing osteoarthritis |
| 05/02/2008 | WO2008028934A8 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 05/02/2008 | WO2008027986A3 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 05/02/2008 | WO2008014410A3 Zimlig2 polynucleotides and polypeptides and methods of use |
| 05/02/2008 | WO2008010864A3 Modified adenovirus hexon protein and uses thereof |
| 05/02/2008 | WO2008009977A3 Methods and compositions for modulating socs3 |
| 05/02/2008 | WO2008003489A8 Cellular pyrogenic test using toll-like receptor |
| 05/02/2008 | WO2008002470A3 Sirna sequences against brf1 |
| 05/02/2008 | WO2007149567A3 Targeting complement factor h for treatment of diseases |
| 05/02/2008 | WO2007144198A3 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases |
| 05/02/2008 | WO2007139791A3 Compositions and methods for the delivery of oxygen |
| 05/02/2008 | WO2007120309A3 Attenuated brucella melitensis mutants |
| 05/02/2008 | WO2007111714B1 Il-21 antagonists |
| 05/02/2008 | WO2007095443A3 Gastrin releasing peptide compounds |
| 05/02/2008 | WO2007061631A8 Production of glycoproteins with reduced o-glycosylation |
| 05/02/2008 | WO2007028574A9 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules |
| 05/02/2008 | WO2007028573A9 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/02/2008 | WO2005013885A3 Pharmaceutical compositions and methods for accelerating wound healing |
| 05/02/2008 | CA2703795A1 Endometrial phase or endometrial cancer biomarkers |
| 05/02/2008 | CA2703646A1 Peptide vaccine for influenza virus |
| 05/02/2008 | CA2703124A1 Methods for diagnosing osteoarthritis |
| 05/02/2008 | CA2667558A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/02/2008 | CA2667537A1 Metastin derivatives and use thereof |
| 05/02/2008 | CA2667075A1 Extracellular matrix cancer vaccine adjuvant |
| 05/02/2008 | CA2666991A1 Peptide-cytotoxic conjugates |
| 05/02/2008 | CA2666981A1 Soluble tnf receptors and their use in treatment of disease |
| 05/02/2008 | CA2666962A1 Human salty taste receptor and methods of modulating salty taste perception |
| 05/02/2008 | CA2666516A1 Neuronal exocytosis inhibiting peptides |
| 05/02/2008 | CA2666426A1 Il-21 variants |
| 05/02/2008 | CA2660439A1 Methods for increasing the resistance in plants to biotropic fungi |
| 05/01/2008 | US20080104731 Second TC complex from Xenorhabdus |
| 05/01/2008 | US20080104721 Nucleic acids isolated from crustaceans; linked to expression regulatory elements; analyzing cells by detection of signal; kits |
| 05/01/2008 | US20080103294 Amino acid substitutions which increases protease resistance; linked to water soluble polymer (polyethylene glycol); improved half-life |
| 05/01/2008 | US20080103293 Amino acid substitutions which increases protease resistance; linked to water soluble polymer (polyethylene glycol); improved half-life |
| 05/01/2008 | US20080103292 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/01/2008 | US20080103291 Nucleic acid of given sequence; membrane preparations or cell lysate from recombinant cell transformed with DNA expression vector |
| 05/01/2008 | US20080103290 Eluting from polystyrene divinyl benzene resin using acidified solution containing organic solvent; antibacterial |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080103097 Glucagon-like peptides having one lipophilic substituent which is attached to the C-terminal amino acid; treatment of non-insulin dependent diabetes mellitus |
| 05/01/2008 | US20080103095 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 05/01/2008 | US20080103087 Azurin, pseudoazurin, plastocyanin, rusticyanin, Laz or auracyanin from Xylella, Pseudomonas, Alcaligene, Achromobacter, Bordetella, Methylomonas, Neisseria, or Vibrio; anticarcinogenic or antitumor agents; diabetic retinopathy, rheumatoid arthritis, psoriasis |
| 05/01/2008 | US20080103055 Polypeptide |
| 05/01/2008 | US20080102510 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 05/01/2008 | US20080102509 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 05/01/2008 | US20080102491 Bacterial host cell for the direct expression of peptides |
| 05/01/2008 | US20080102490 Interferon-like protein zcyto21 |
| 05/01/2008 | US20080102489 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 05/01/2008 | US20080102472 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 05/01/2008 | US20080102471 Expression vector comprising nucleotide sequences coding myeblastosis (MYB) regulatory proein for use as tool in controlling heterologus gene expression in plants |
| 05/01/2008 | US20080102446 Using viral suface proteins as tools in detection and quantification of viruses in biolgical samples |
| 05/01/2008 | US20080102445 Using viral suface proteins as tools in detection and quantification of viruses in biolgical samples |
| 05/01/2008 | US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment |
| 05/01/2008 | US20080102088 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102084 Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102080 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 05/01/2008 | US20080102079 Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102066 Ultrapure transferrin for pharmaceutical compositions |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 04/30/2008 | EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses |
| 04/30/2008 | EP1916303A1 Nucleic acids encoding rearranged human immunoglobulin sequences from transgenic transchromosomal mice |